X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adult (4) 4
aged (4) 4
double-blind method (4) 4
female (4) 4
humans (4) 4
index medicus (4) 4
male (4) 4
middle aged (4) 4
blood glucose - metabolism (3) 3
care and treatment (3) 3
diabetes mellitus, type 2 - blood (3) 3
diabetes mellitus, type 2 - drug therapy (3) 3
efficacy (3) 3
empagliflozin (3) 3
glycemic control (3) 3
metformin (3) 3
safety (3) 3
treatment outcome (3) 3
type 2 diabetes (3) 3
benzhydryl compounds - administration & dosage (2) 2
benzhydryl compounds - adverse effects (2) 2
benzhydryl compounds - therapeutic use (2) 2
blood glucose - drug effects (2) 2
blood pressure (2) 2
blood pressure - drug effects (2) 2
body weight - drug effects (2) 2
cardiac & cardiovascular systems (2) 2
double-blind (2) 2
endocrinology & metabolism (2) 2
glucose (2) 2
glucosides - administration & dosage (2) 2
glucosides - adverse effects (2) 2
glucosides - therapeutic use (2) 2
glycated hemoglobin a - metabolism (2) 2
hypoglycemia (2) 2
hypoglycemic agents (2) 2
hypoglycemic agents - administration & dosage (2) 2
hypoglycemic agents - adverse effects (2) 2
hypoglycemic agents - therapeutic use (2) 2
sglt2 inhibitor (2) 2
weight-loss (2) 2
young adult (2) 2
[ sdv ] life sciences [q-bio] (1) 1
abridged index medicus (1) 1
acute disease (1) 1
add-on (1) 1
adolescent (1) 1
analysis (1) 1
antagonists & inhibitors (1) 1
antagonists & inhibitors; hemorrhage; recurrence; thrombin; venous thromboembolism; warfarin (1) 1
anticoagulants (1) 1
anticoagulants - administration & dosage (1) 1
anticoagulants - adverse effects (1) 1
antithrombins (1) 1
antithrombins - administration & dosage (1) 1
antithrombins - adverse effects (1) 1
apixaban (1) 1
benzimidazoles (1) 1
benzimidazoles - administration & dosage (1) 1
benzimidazoles - adverse effects (1) 1
beta-alanine (1) 1
beta-alanine - administration & dosage (1) 1
beta-alanine - adverse effects (1) 1
beta-alanine - analogs & derivatives (1) 1
biomarkers - blood (1) 1
cardiology and cardiovascular medicine (1) 1
cardiovascular diseases (1) 1
confidence intervals (1) 1
controlled-trial (1) 1
cotransporter 2 inhibition (1) 1
dabigatran (1) 1
dabigatran etexilate (1) 1
diabetes (1) 1
diabetes mellitus, type 2 - diagnosis (1) 1
diabetes mellitus, type 2 - physiopathology (1) 1
diabetes therapy (1) 1
dose-response relationship, drug (1) 1
drug dosages (1) 1
drug therapy, combination (1) 1
drug therapy, combination - methods (1) 1
endocrinology, diabetes and metabolism (1) 1
follow-up studies (1) 1
fondaparinux (1) 1
glycaemic control (1) 1
glycated hemoglobin a - analysis (1) 1
hemorrhage (1) 1
hemorrhage - chemically induced (1) 1
hemorrhage - epidemiology (1) 1
heparin (1) 1
heparin - administration & dosage (1) 1
heparin - adverse effects (1) 1
heparin, low-molecular-weight (1) 1
heparin, low-molecular-weight - administration & dosage (1) 1
heparin, low-molecular-weight - adverse effects (1) 1
hyperglycemia (1) 1
infections (1) 1
initial treatment (1) 1
insulin (1) 1
internal medicine (1) 1
key words empagliflozin (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 2014, Volume 129, Issue 7, pp. 764 - 772
Dabigatran and warfarin have been compared for the treatment of acute venous thromboembolism (VTE) in a previous trial. We undertook this study to extend those... 
Antagonists & inhibitors | Recurrence | Thrombin | Warfarin | Hemorrhage | Venous thromboembolism | CARDIAC & CARDIOVASCULAR SYSTEMS | FONDAPARINUX | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | RIVAROXABAN | INITIAL TREATMENT | PERIPHERAL VASCULAR DISEASE | ORAL ANTICOAGULANT-THERAPY | APIXABAN | UNFRACTIONATED HEPARIN | Anticoagulants - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Heparin - administration & dosage | Heparin, Low-Molecular-Weight - adverse effects | Warfarin - adverse effects | Male | Antithrombins - administration & dosage | Dabigatran | Heparin - adverse effects | Warfarin - administration & dosage | Venous Thromboembolism - drug therapy | Young Adult | Benzimidazoles - administration & dosage | Adult | Female | Benzimidazoles - adverse effects | Venous Thromboembolism - epidemiology | beta-Alanine - analogs & derivatives | Acute Disease | beta-Alanine - adverse effects | Double-Blind Method | Hemorrhage - epidemiology | Risk Factors | beta-Alanine - administration & dosage | Anticoagulants - adverse effects | Antithrombins - adverse effects | Adolescent | Aged | Hemorrhage - chemically induced | Heparin, Low-Molecular-Weight - administration & dosage | Usage | Care and treatment | Dabigatran etexilate | Thromboembolism | Anticoagulants | Benzimidazoles | Heparin, Low-Molecular-Weight | Life Sciences | Venous Thromboembolism | Antithrombins | Heparin | beta-Alanine
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2015, Volume 37, Issue 8, pp. 1773 - 1788.e1
Journal Article
Cardiovascular Diabetology, ISSN 1475-2840, 12/2015, Volume 14, Issue 1, p. 154
Journal Article
Diabetes Research and Clinical Practice, ISSN 0168-8227, 2015, Volume 110, Issue 1, pp. 82 - 90
Journal Article
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 21, pp. 205 - 205
Abstract Abstract 205 Background: Dabigatran has been compared with warfarin for treatment of acute venous thromboembolism in one previous trial (RE-COVER).... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.